Cognitive Dysfunction in Type 2 Diabetes Mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.diagnosis of type 2 diabetes mellitus; 2.with an age of 18 to 74 years; 3.a diabetes management model compatible with AI-assisted management and wearable device monitoring; 4.can provide complete documentation of lifestyle, including medical history, medication records, diet, and physical activity; 5.fully understand the purpose, nature, and methods of the study; voluntarily agree to participate; commit to the 12-month follow-up period; and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.patients who are unwilling or unable to sign the informed consent form; 2.currently participating in another clinical research study, where participation is defined as having signed the informed consent form; 3.women who are pregnant or planning pregnancy; 4.type 1 diabetes mellitus and specific types of diabetes; 5.patients with heart failure of New York Heart Association (NYHA) class III-IV; 6.patients with an estimated glomerular filtration rate (eGFR) of less than 30 mL/min/1.73m²; 7.patients with cognitive decline secondary to a severe cerebrovascular accident; 8.patients with severe systemic infection; 9.patients with a diagnosis of malignancy; 10.meet the criteria for dementia based on cognitive function assessment at enrollment; 11.a long-term history of substance use disorder or alcohol use disorder; 12.patients with severe psychiatric disorders who are unable to cooperate;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medical test indicators;data parameters derived from smart wearable devices; | — |
Countries
China
Contacts
First Affiliated Hospital of Kunming Medical University